Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone plus metformin versus metformin alone versus rosiglitazone alone in obese women with polycystic ovary syndrome and metabolic disorders
ChiCTR-TRC-13003642Phase 4Completed
- Sponsor
- West China Second University Hospital
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in polycystic ovary syndrome (PCOS) comparing Metformin, Rosiglitazone and Rosiglitazone + metformin (3 arms). Primary endpoints: HOMA-IR and blood lipids. Started Oct 2013; status: completed.
02
Drugs
metforminrosiglitazone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR-TRC-13003642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003642.